Search bioRxiv⌕ Search

Biology subjects

Turner, H. C.

Publications and source records attributed to Turner, H. C..

5 recordsLinked to original sources

Predicting neutron radiation exposure characteristics from an in vitro human skin model using RNA-seq

Accurate assessment of low-dose neutron radiation exposure remains a central challenge in biodosimetry, particularly for applications requiring non-invasive sample types such as skin. Here, we characterized the transcriptional response of a three-dimensional in vitro human skin model (EpiDermFT) to neutron irradiation at doses up to 0.75 Gy, measured from pre-exposure through a 14-day post-exposure period. RNA sequencing revealed greater than 800 significantly altered genes, including upregulation of FOS, FOSB, CDKN1A, MDM2, and GADD45A, and downregulation of NRG1, H3C11, and CENPX. Gene ontology enrichment indicated activation of DNA damage checkpoint signaling, cell cycle arrest, and stress-response pathways, alongside suppression of nucleosome assembly and DNA replication processes. Machine learning models trained on transcriptomic features exhibited strong predictive performance across biodosimetric endpoints. Classification models accurately distinguished irradiated from sham samples (AUC > 0.99), and regression models achieved high accuracy for estimating both absorbed dose (R2 = 0.97) and days post-exposure (R2 = 0.99). The latter, while highly predictive, may partially reflect transcriptional shifts associated with progressive degradation of the in vitro tissue model over time. Collectively, these findings demonstrate that RNA-based molecular signatures from human skin tissue provide a robust framework for quantitative estimation of neutron radiation exposure and temporal response dynamics.

genomics↗

MIIST305 mitigates gastrointestinal acute radiation syndrome injury and ameliorates radiation-induced gut microbiome dysbiosis

High-dose radiation exposure results in gastrointestinal (GI) acute radiation syndrome identified by the destruction of mucosal layer, intestinal epithelial barrier dysfunction, and aberrant inflammatory responses. In addition, radiation causes gut microbiome dysbiosis characterized by diminished microbial diversity, reduction in the abundance of beneficial commensal bacteria, and the spread of bacterial pathogens that trigger the recruitment of immune cells and the production of pro-inflammatory factors that lead to further GI tissue damage. Currently, there are no FDA- approved countermeasures that can treat radiation-induced GI injury. To meet this critical need, Synedgen Inc., has developed a glycopolymer radiomitigator (MIIST305) that is specifically targeted to the GI tract which acts by intercalating into the mucus layer and the glycocalyx of intestinal epithelial cells that could potentially ameliorate the deleterious effects of radiation. Male C57BL/6J adult mice were exposed to 13 Gy total body X-irradiation with 5% bone marrow shielding and MIIST305 was administered on days 1, 3, and 5 post-irradiation. Approximately 85% of the animals survived the irradiation exposure and were apparently healthy until the end of the 30-day study period. In contrast, no control, vehicle-treated animals survived past day 10 at this radiation dose. We show that MIIST305 improved intestinal epithelial barrier function and suppressed systemic inflammatory response mediated by radiation-induced pro-inflammatory cytokines. Taxonomic profiling and community structure of the fecal and colonic mucosa microbiota demonstrated that MIIST305 treatment increased microbial diversity and restored abundance of beneficial commensal bacteria, including Lactobacillus and Bifidobacterium genera, while suppressing potentially pathogenic bacteria compared with vehicle-treated animals. In summary, MIIST305 is a novel GI-targeted therapeutic that greatly enhances survival in mice exposed to lethal radiation and protects the GI tract from injury by restoring a balanced gut microbiota and effectively reducing proinflammatory responses. Further development of this drug as an FDA-approved medical countermeasure will be of critical importance in the event of a radiation public health emergency.

microbiology↗

DNA damage response in peripheral mouse blood leukocytes in vivo after variable, low-dose rate exposure

Environmental contamination and ingestion of the radionuclide Cesium-137 (137Cs) is a large concern in fallout from a nuclear reactor accident and improvised nuclear device and highlights the need to develop biological assays for low dose rate, internal emitter radiation. To mimic low dose rates attributable to fallout, we have developed a VAriable Dose-rate External 137Cs irradiatoR (VADER), which can provide arbitrarily varying and progressive low dose rate irradiations in the range of 1.2 to 0.1 Gy/day, while circumventing the complexities of dealing with radioactively-contaminated biomaterials. We investigated the kinetics of mouse peripheral leukocytes DNA damage response in vivo after variable, low-dose rate 137Cs exposure. C57BL/6 mice were placed in the VADER over 7 days with total accumulated dose up to 2.7 Gy. Peripheral blood response including the leukocytes depletion, apoptosis signal protein p53 and DNA repair biomarker {gamma}-H2AX were measured. The results illustrated that blood leukocyte count had significantly dropped by days 7. P53 levels peaked at day 2 (total dose=0.91Gy) and then declined whereas {gamma}-H2AX yields generally increased with accumulated dose and peaked at day 5 (total dose=2.08Gy). ROC curve analysis for {gamma}-H2AX provided a good discrimination of accumulated dose < 2 Gy and [&ge;] 2 Gy, highlighting the potential of {gamma}-H2AX as a biomarker dosimetry in a protracted, environmental exposure scenario.

cell biology↗

New High Throughput Approaches to Detect Partial-body and Neutron Exposures on an Individual Basis

Biodosimetry-based discrimination between homogeneous total-body photon exposure and complex irradiation scenarios (partial-body shielding and/or neutron + photon mixtures) can improve treatment decisions after mass-casualty radiation-related incidents. Our study objective was to use high-throughput biomarkers to: a) detect partial-body and/or neutron exposure on an individual basis, and b) estimate separately the photon and neutron doses in a mixed exposure. We developed a novel approach, where metrics related to the shapes of micronuclei distributions per binucleated cell in ex-vivo irradiated human lymphocytes (variance/mean, kurtosis, skewness, etc.) served as predictors in machine learning or parametric analyses of the following scenarios: (A) Homogeneous gamma-irradiation, mimicking total-body exposures, vs. mixtures of irradiated blood with unirradiated blood, mimicking partial-body exposures. (B) X rays vs. various neutron + photon mixtures. Classification of samples as homogeneously vs. heterogeneously irradiated (scenario A) achieved a receiver operating characteristic curve area (AUROC) of 0.931 (uncertainty range of 0.903-0.951), and R2 for actual vs. reconstructed mean dose was 0.87. Detection of samples with [&ge;]10% neutron contribution (scenario B) achieved AUROC of 0.916 (0.893-0.943), and R2 for reconstructing photon-equivalent dose was 0.77. These encouraging findings demonstrate a proof-of-principle for the proposed approach of analyzing micronuclei/cell distributions to detect clinically-relevant complex radiation exposure scenarios.

biophysics↗

Development of a high-throughput γ-H2AX assay based on imaging flow cytometry

BackgroundMeasurement of {gamma}-H2AX foci formation in cells provides a sensitive and reliable method for quantitation of the radiation-induced DNA damage response. The objective of the present study was to develop a rapid, high-throughput {gamma}-H2AX assay based on imaging flow cytometry (IFC) using the ImageStream(R)X Mk II (ISX MKII) platform to evaluate DNA double strand break (DSB) repair kinetics in human peripheral blood cells after exposure to ionizing irradiation.\n\nMethodsThe {gamma}-H2AX protocol was optimized for small volumes (100 {micro}l) of blood in Matrix 96-tube format and blood cell lymphocytes were identified and captured by ISX INSPIRE software and analyzed by Data Exploration and Analysis Software.\n\nResultsPresented here are: 1) dose response curves based on {gamma}-H2AX fluorescence intensity and foci number, 2) measurements of DNA repair kinetics up to 24 h after exposure to 4 Gy {gamma} rays and, 3) a mathematical approach for modeling DNA DSB rejoining kinetics using two key parameters a) rate of {gamma}-H2AX decay, and b) yield of residual unrepaired breaks.\n\nConclusionsThe results indicate that the IFC-based {gamma}-H2AX protocol may provide a practical, high-throughput and inexpensive platform for measurements of individual global DSB repair capacity and facilitate the prediction of precision medicine concepts.

cell biology↗